Iran
War, sanctions and inflation leave Iran short of hundreds of medicines
Prices for basic medicines such as paracetamol and insulin have skyrocketed amid major shortages of less common pharmaceuticals. More than 70% of healthcare costs in Iran are paid out of pocket, leaving the most vulnerable patients unable to afford treatment.
Business
US launches trade probe into Germany over medicine prices
Washington has accused Berlin of artificially capping medicine prices while the US market pays significantly more for identical products. If a pending trade investigation finds Germany’s policies unfair, the United States could hit back with punitive tariffs.
Health news
Drug monopoly extension splits EU ministers in Biotech Act debate
EU health ministers split over a proposal to give certain innovative medicines an extra year of market protection, with EU Health Commissioner arguing the incentive is needed to keep biotech investment in Europe. Incoming Irish presidency, in the meantime, says it will work as quickly as possible.
Health news
Why weight loss drugs aren't Denmark's trump card in Greenland dispute
Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration during Greenland talks, experts say.